-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-144-fullreport.pdf
January 01, 2020 - Children With Disabilities Algorithm
Children with Disabilities Algorithm
Section 1. Basic Measure Information
1.A. Measure Name
Children with Disabilities Algorithm (CWDA)
1.B. Measure Number
0144
1.C. Measure Description
Please provide a non-technical description of the measure that conveys what it measur…
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/2024-11/uspstf-annual-report-congress-2024.pdf
January 01, 2024 - 14th Annual Report to Congress: High-Priority Evidence Gaps Across the Lifespan, in All Communities
November 2021
High-Priority Evidence Gaps Across
the Lifespan, in All Communities
Commemorating 40 Years of Making Evidence-Based
Recommendations for Preventive Services
SUBMITTED BY:
Dr. Wanda K. Nicholson, Chair…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy-update_disposition-comments.pdf
September 10, 2014 - Disposition of Comments Report for Core Needle and Open Surgical Biopsy for Diagnosis of Breast Lesions: An Update to the 2009 Report
Comparative Effectiveness Review Disposition of Comments Report
Research Review Title: Core Needle and Open Surgical Biopsy for Diagnosis of Breast
Lesions: An Update to th…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-therapies-update_disposition-comments.pdf
December 16, 2014 - Disposition of Comments for Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer: An Update of a 2008 Systematic Review
Comparative Effectiveness Review Disposition of Comments Report
Research Review Title: Comparative Effectiveness of Therapies for Clinically Localized
Prostat…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_executive.pdf
January 01, 2016 - 1
Comparative Effectiveness Review
Number 168
Diagnosis and Management of Infantile
Hemangioma
Executive Summary
Introduction
Infantile hemangiomas (IH) are the most
common tumors of childhood. IH are
benign but possess potential for local
tissue damage, ulceration, infection,
bleeding, functional impact, and…
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/anticoagulants-1.pdf
March 01, 2020 - Chapter-7 - Harm Due to Anticoagulants
Harms Due to Anticoagulants 7-1
7. Harms Due to Anticoagulants
Authors: Sarah J. Shoemaker-Hunt, Ph.D., Pharm.D., and Brandy Wyant, M.P.H.
Introduction
Anticoagulants are a critical therapy in the prevention and treatment of various types of
thromboembolic disorders. Key in…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-203-adhd-disposition-comments.pdf
January 01, 2018 - Disposition of Comments Report for CER 203 ADHD
Comparative Effectiveness Review Disposition of Comments Report
Research Review Title:
Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment in Children and
Adolescents
Draft review available for public comment from October 17, 2016, to November 14, …
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/peripheral-artery-disease-treatment_research-protocol.pdf
January 31, 2013 - Source: www.effectivehealthcare.ahrq.gov
Originally published online: January 31, 2012; Amended January 31, 2013
Evidence-based Practice Center Systematic Review Protocol
Project Title: Treatment Strategies for Patients With Peripheral Artery Disease (PAD)
Amendment Date(s): January 31, 2013
(Amendment Detai…
-
www.ahrq.gov/practiceimprovement/systemdesign/leancasestudies/lean-case1.html
November 01, 2014 - The hospital is home to the one of the first acute care units for the elderly in the region and considers
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ear-infection_disposition-comments.pdf
May 04, 2013 - /language delays or disorders, craniofacial anomalies, or
syndromes that involve the head and neck region
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
September 01, 2022 - hospital-associated and community-
associated meticillin-resistant
Staphylococcus aureus infections across a
region
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
September 01, 2022 - hospital-associated and community-
associated meticillin-resistant
Staphylococcus aureus infections across a
region
-
effectivehealthcare.ahrq.gov/sites/default/files/antipsychotics-children-update_executive.pdf
January 01, 2018 - benefits
and harms across groups defined by race/ethnicity,
socioeconomic status, and geographical region
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/Z6Rfj-qwfoMbuLp-hBmhzS
May 01, 2021 - 23
2012
US
Cross-
sectional (fair)
Medicare recipients
(n = 452) from greater
Philadelphia metro
region
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/Rm4E5SooP2GnqJ_HVRA5M4
January 01, 2017 - et al29 2012
United States
452 Cross-sectional Medicare
recipients
from greater
Philadelphia
metro region
-
www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/primary-care-based-efforts.pdf
March 01, 2019 - Number, rate, and average length of
stay for discharges from short-stay hospitals, by age, region, and
-
effectivehealthcare.ahrq.gov/sites/default/files/functional-limitations-horizon-scan-high-impact-1306.pdf
June 01, 2013 - Humana, Inc. 2012 prescription drug guide
Humana formulary [Region 21].
-
www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/PrimaryCareEffortsToReduceReadmissions-envscan.pdf
March 01, 2020 - Number, rate, and average length of
stay for discharges from short-stay hospitals, by age, region, and
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/_SBmXPhUQWo-dc85FJ5wHf
February 01, 2015 - Re-
sults did not seem to vary by geographic region or
population baseline characteristics.
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/osteoporosis-screening
January 14, 2025 - Predictive capacity of FRAX in a spanish region with a hip fracture rate close to the national mean.